The divergent function of androgen receptor in breast cancer
Diabetes Obes Metab 25:18131822 Palmer SC, Tendal B, Mustafa RA, Vandvik PO, Li S, Hao Q, Tunnicliffe D, Ruospo M, Natale P, Saglimbene V, Nicolucci A, Johnson DW, Tonelli M, Rossi MC, Badve SV, Cho Y, Nadeau-Fredette AC, Burke M, Faruque LI, Lloyd A, Ahmad N, Liu Y, Tiv S, Millard T, Gagliardi L, Kolanu N, Barmanray RD, McMorrow R, Raygoza Cortez AK, White H, Chen X, Zhou X, Liu J, Rodriguez AF, Gonzalez-Colmenero AD, Wang Y, Li L, Sutanto S, Solis RC, Diaz Gonzalez-Colmenero F, Rodriguez-Gutierrez R, Walsh M, Guyatt G, Strippoli GFM (2021) Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
Some reports indicate that higher dosages are related to more significant side effects and potential injuries
6.3 Patient population in the PIONEER program (PIONEER 18) Across the PIONEER program, the majority of patients were adults ( 18 years) with a diagnosis of T2D and baseline HbA 1c levels in the range of 7.09.5% [38, 39, 61, 62, 76,77,78,79,80,81,82]
Sometimes, you might find the best option is to limit certain foods that cause a reaction
The maintenance phase needs clearer guidance than that
